Pervasive Adaptation of Hepatitis C Virus to Interferon Lambda Polymorphism Across Multiple Genotypes
Nimisha Chaturvedi(Alstom (France)), Jacques Fellay(SIB Swiss Institute of Bioinformatics), John G. McHutchison(Gilead Sciences (United States)), G. Mani Subramanian(Pacific Biosciences (United States)), Stefan Zeuzem(Goethe University Frankfurt), Diana M. Brainard(Gilead Sciences (United States)), Hongmei Mo(Gilead Sciences (United States)), Evguenia S. Svarovskaia(University of Miami), Anu Osinusi(Gilead Sciences (United States))
Cited by 0
Related Papers
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
|New England Journal of Medicine|2013|1.8k
Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
|New England Journal of Medicine|2014|1.1k
Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
|New England Journal of Medicine|2013|1.1k